MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

A.I. Advisor
published Earnings

SUPN is expected to report earnings to rise 30.00% to 51 cents per share on November 11

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q3'25
Est.
$0.52
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.58
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.25
The last earnings report on August 05 showed earnings per share of 40 cents, missing the estimate of 47 cents. With 284.99K shares outstanding, the current market capitalization sits at 2.27B.
View a ticker or compare two or three
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SUPN showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com